Integra LifeSciences is a global leader in medical technology, dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. We offer a comprehensive portfolio of products and solutions for neurosurgery, extremity reconstruction, and regenerative wound care. Our innovative technologies empower healthcare professionals to improve patient outcomes and advance the standards of care worldwide.
Serves as the central hub for global operations, strategic decision-making, research and development leadership, and corporate functions.
Modern corporate campus featuring advanced research labs, collaborative workspaces, and administrative offices designed to support innovation in medical technology.
Emphasizes innovation, patient-centricity, integrity, and collaboration. Employees are driven by the mission to limit uncertainty for clinicians and improve patient outcomes globally.
Strategically located in New Jersey's 'Einstein Alley' life sciences corridor, providing access to a rich talent pool, research institutions, and industry partners, reinforcing its position as a key player in medical technology.
Integra LifeSciences operates globally, with commercial, manufacturing, and research and development facilities supporting customers in over 130 countries. Key functions supported globally include sales and marketing, distribution, clinical support, product development, and regulatory affairs across its neurosurgery, surgical instrumentation, and regenerative wound care portfolios. This expansive network allows Integra to address diverse healthcare needs and advance medical technology worldwide.
1100 Campus Road
Princeton
New Jersey
USA
Address: Parc Technologique de la Porte des Alpes, Bâtiment l'Initial, 270 Allée des Ginkgos, 69800 Saint Priest, France
Manages and supports Integra's business activities across Europe, the Middle East, and Africa, ensuring localized market strategies and customer engagement.
Address: Integra LifeSciences Services (Singapore) Pte. Ltd., 2 Tukang Innovation Grove, #08-01, JTC MedTech Hub, Singapore 618305
Drives strategic growth and market penetration in the diverse Asia-Pacific region, adapting solutions to meet local healthcare needs and regulatory landscapes.
Address: 311 Enterprise Drive, Plainsboro, NJ 08536, USA
Supports the North American market with product innovation, manufacturing capabilities, and operational excellence, playing a crucial role in the company's supply chain and R&D efforts.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Integra LifeSciences' leadership includes:
Integra LifeSciences has been backed by several prominent investors over the years, including:
Over the past 12 months, Integra LifeSciences has made significant leadership appointments, including a new Chief Medical Officer and new presidents for its Codman Specialty Surgical and Tissue Technologies divisions. These changes are aimed at driving strategic growth, innovation, and operational excellence within its core business segments.
Discover the tools Integra LifeSciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Integra LifeSciences commonly uses the 'first.last@integralife.com' email format. Other formats might be used less frequently. For example, 'john.doe@integralife.com' would be a typical structure.
first.last@integralife.com
Format
jane.doe@integralife.com
Example
85%
Success rate
Integra LifeSciences Investor Relations • February 21, 2024
Integra LifeSciences announced its financial results for Q4 and full-year 2023, reporting revenues of $397.6 million for Q4 and $1.55 billion for the full year. The company provided insights into its performance, including updates on the Boston facility recall, and its outlook for 2024....more
Integra LifeSciences Press Release • January 2, 2024
Integra LifeSciences announced the appointment of Dr. Stuart A. Hart as executive vice president and Chief Medical Officer, effective January 2, 2024. Dr. Hart will lead the company's global medical affairs organization and oversee pre-clinical and clinical research programs....more
Integra LifeSciences Press Release • December 5, 2023
Integra LifeSciences announced the completion of its acquisition of a portfolio of surgical instruments from Medtronic, including the MicroFrance™ and Xomed™ manual ENT and laparoscopic surgical instruments. This acquisition expands Integra's offerings in these surgical areas....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Integra LifeSciences, are just a search away.